-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Spero Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
- Spero Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was 13.1 %.
- Spero Therapeutics, Inc. annual Operating Margin for 2023 was 20.7 %.
- Spero Therapeutics, Inc. annual Operating Margin for 2022 was -78.9 %, a 83.6% increase from 2021.
- Spero Therapeutics, Inc. annual Operating Margin for 2021 was -482 %, a 43.2% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)